Streetbeat News

Stock Prices

AZN

AstraZeneca's Phase 3 trial of Imfinzi in early-stage non-small cell lung cancer did not achieve statistical significance for the primary endpoint of disease-free survival compared to placebo.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 9:02 am

AZN

AstraZeneca's NIAGARA Phase 3 trial of Imfinzi (Durvalumab) combined with chemotherapy demonstrated statistically significant and clinically meaningful improvements in event-free survival and overall survival compared to neoadjuvant chemotherapy in muscle-invasive bladder cancer.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 8:59 am

GOOGL

TSLA

XPEV

XPeng CEO He Xiaopeng predicts that 2025 will be the 'ChatGPT moment' for fully autonomous driving after testing Tesla's FSD and Waymo's technologies. He praised Tesla's progress and expressed interest in further testing. XPeng also invited Elon Musk to test its XNGP system in China.

Portfolio Pulse from Anan Ashraf

June 25, 2024 | 8:25 am

GOOGL

TSLA

UBER

Emil Michael, former Uber executive, expressed skepticism about the financial feasibility of robotaxis due to high production costs. He highlighted that the cost of a Waymo vehicle is around $300K, making it financially unviable to replace human drivers soon. RBC Capital Markets reduced Tesla's price target due to lower robotaxi pricing assumptions. Uber remains a top pick for travel stocks, with analysts noting that full autonomous vehicles are still years away. General Motors announced an $850 million investment for its Cruise self-driving unit.

Portfolio Pulse from Benzinga Neuro

June 25, 2024 | 7:38 am

TSLA

Tesla Inc (NASDAQ:TSLA) has reopened the option for customers to transfer its Full Self-Driving (FSD) capability from older vehicles to new ones, available for deliveries between June 24 and August 31. This move aims to boost FSD adoption amid declining EV deliveries and falling share value.

Portfolio Pulse from Anan Ashraf

June 25, 2024 | 7:36 am

LOGI

Logitech G, a brand of Logitech, has unveiled the G515 LIGHTSPEED TKL Wireless Gaming Keyboard, featuring advanced technologies and high-performance features in a low-profile design. The keyboard includes innovations such as LIGHTSPEED, LIGHTSYNC, and KEYCONTROL, offering gamers enhanced customization and performance.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 7:06 am

Chemours Company announced that the Mexican government has lifted water intake restrictions, allowing the company to resume normal operations at its Titanium Dioxide (TiO2) manufacturing facility in Altamira, Mexico.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 6:55 am

ALIM

ANIP

CCL

FDX

NVDA

SNX

The Nasdaq Composite experienced its worst session since April, with Nvidia plunging 7%. The Dow Jones saw modest gains, closing over 260 points higher. Alimera Sciences surged 76% after announcing an acquisition by ANI Pharmaceuticals. Investors are awaiting earnings results from Carnival Corporation, FedEx, and TD SYNNEX.

Portfolio Pulse from Avi Kapoor

June 25, 2024 | 6:45 am

TSLA

Elon Musk reassures Tesla investors of 'exceptional' long-term returns despite a 26% decline in stock value this year. Tesla's performance has impacted Baron Partners Fund, which remains bullish on the company. Tesla faces industry headwinds, competitive pressure, and margin erosion due to price cuts. The company is shifting focus to AI, robotics, and ancillary businesses like full self-driving technology and energy. Cathie Wood’s Ark Invest predicts Tesla stock could reach $2,600 by 2029.

Portfolio Pulse from Shanthi Rexaline

June 25, 2024 | 6:26 am

AMD

ARM

INTC

QCOM

Arm Holdings CEO Rene Haas believes analysts have underestimated the rapid growth of AI, which is significantly impacting the company's performance. Arm Holdings, recently added to the Nasdaq 100, has seen its stock surge nearly 140% since its public debut in September. The company is positioning itself as a major player in the AI chip market, despite facing legal challenges with Qualcomm.

Portfolio Pulse from Benzinga Neuro

June 25, 2024 | 5:57 am